Incannex Healthcare (Incannex Healthcare) Cash And Cash Equivalents : $9.31 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Incannex Healthcare Cash And Cash Equivalents?

Incannex Healthcare's quarterly cash and cash equivalents increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($14.55 Mil) but then stayed the same from Dec. 2023 ($14.55 Mil) to Mar. 2024 ($9.31 Mil).

Incannex Healthcare's annual cash and cash equivalents increased from Jun. 2021 ($6.86 Mil) to Jun. 2022 ($25.80 Mil) but then declined from Jun. 2022 ($25.80 Mil) to Jun. 2023 ($22.08 Mil).

Incannex Healthcare Cash And Cash Equivalents Historical Data

The historical data trend for Incannex Healthcare's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incannex Healthcare Cash And Cash Equivalents Chart

Incannex Healthcare Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.07

2.48

6.86

25.80

22.08

Incannex Healthcare Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															-	22.08	-	14.55	9.31

Incannex Healthcare Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Incannex Healthcare (NAS:IXHL) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Incannex Healthcare Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Incannex Healthcare's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Incannex Healthcare (Incannex Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Incannex Healthcare Inc (NAS:IXHL) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Century Circuit Norwest, Suite 105, Sydney, NSW, AUS, 3000

Website

https://www.incannex.com.au

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.